ArticleInternational journal of immunopathology and pharmacology

CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma.

Xiaohu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.